Gene · 5105
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells. | Cell Death Discov | 2023 | 38065937 | PubTator, text mining | PubMed |
| Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury. | Front Cell Dev Biol | 2023 | 38054182 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors. | Front Oncol | 2023 | 38053661 | PubTator, text mining | PubMed |
| Cefminox sodium alleviates the high-fat high-sugar-fed mice's hepatic fatty accumulation via multiple pathways. | Heliyon | 2023 | 38027801 | PubTator, text mining | PubMed |
| Addressing the preventive and therapeutic perspective of berberine against diabetes. | Heliyon | 2023 | 38027723 | PubTator, text mining | PubMed |
| Resistance to immune checkpoint inhibitors in gastric cancer. | Front Pharmacol | 2023 | 38026944 | PubTator, text mining | PubMed |
| MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism. | iScience | 2023 | 38026196 | PubTator, text mining | PubMed |
| hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner. | J Transl Med | 2023 | 38017546 | PubTator, text mining | PubMed |
| Proteomic analysis of chromophobe renal cell carcinoma and benign renal oncocytoma biopsies reveals shared metabolic dysregulation. | Clin Proteomics | 2023 | 38017382 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Two-Dimensional-PAGE Coupled with nLC-MS/MS-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in MCF7 Breast Cancer Cells Transfected for JTB Protein Silencing. | Molecules | 2023 | 38005222 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals the molecular response to heat stress in a "red tide" dinoflagellate. | Genome Biol | 2023 | 37996937 | PubTator, text mining | PubMed |
| Inferring mitochondrial and cytosolic metabolism by coupling isotope tracing and deconvolution. | Nat Commun | 2023 | 37980339 | PubTator, text mining | PubMed |
| Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy. | Cell Death Discov | 2023 | 37978169 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma. | South Asian J Cancer | 2023 | 37969675 | PubTator, text mining | PubMed |
| Regulation of Macronutrients in Insulin Resistance and Glucose Homeostasis during Type 2 Diabetes Mellitus. | Nutrients | 2023 | 37960324 | PubTator, text mining | PubMed |
| Biochemical and Molecular Characterization of Musa sp. Cultured in Temporary Immersion Bioreactor. | Plants (Basel) | 2023 | 37960126 | PubTator, text mining | PubMed |
| Organ-Specificity of Breast Cancer Metastasis. | Int J Mol Sci | 2023 | 37958607 | PubTator, text mining | PubMed |
| Delivery and Transcriptome Assessment of an In Vitro Three-Dimensional Proximal Tubule Model Established by Human Kidney 2 Cells in Clinical Gelatin Sponges. | Int J Mol Sci | 2023 | 37958530 | PubTator, text mining | PubMed |
| FOXO inhibition rescues α-defensin expression in human intestinal organoids. | Proc Natl Acad Sci U S A | 2023 | 37956278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5105/papers?page=14